Atlas Trials

Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)

Clinical trial NCT07166211 · RECRUITING

Trial details

NCT number
NCT07166211
Sponsor
Keymed Biosciences Co.Ltd
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Spontaneous Urticaria (CSU)
Start date
2025-11-27
Primary completion
2026-11-02
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.